Forxiga (dapagliflozin) has emerged as a game-changer in managing chronic kidney disease (CKD). Traditionally used as a treatment for Type 2 diabetes, Forxiga is now recognized for its kidney-protective benefits, offering hope to millions of CKD patients worldwide. Glad to be able to share with group of doctors from LifeCare Diagnostic, led by Dr Ong!
How Forxiga Works in CKD
Forxiga belongs to a class of medications known as SGLT2 inhibitors, which work by helping the kidneys remove excess glucose through urine. Beyond its glucose-lowering effects, Forxiga has been shown to reduce the progression of kidney disease by improving kidney function, lowering protein in the urine, and reducing the risk of kidney failure.
Forxiga’s Clinical Benefits in CKD
Recent studies have demonstrated Forxiga’s ability to significantly delay CKD progression. This means fewer patients advancing to end-stage renal disease (ESRD) and reduced dependence on dialysis or kidney transplants. It has also been shown to lower cardiovascular risks, which is a common complication for CKD patients.
Who Can Benefit from Forxiga?
Forxiga is not just for diabetic patients. Recent guidelines recommend its use in CKD patients with or without diabetes, making it an essential treatment option for a broader patient population.
Conclusion
Forxiga offers a promising solution for those suffering from chronic kidney disease. With its ability to slow disease progression and improve overall kidney health, Forxiga is a vital part of modern CKD treatment strategies.
Great discussion, great sharing & great food!